-
1
-
-
84903616595
-
Escherichia coli ST131, an intriguing clonal group
-
Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27:543-74. http://dx.doi.org/10.1128/CMR.00125-13
-
(2014)
Clin Microbiol Rev
, vol.27
, pp. 543-574
-
-
Nicolas-Chanoine, M.H.1
Bertrand, X.2
Madec, J.Y.3
-
2
-
-
76749123412
-
Molecular epidemiology of Escherichia coli producing CTX-M b-lactamases: The worldwide emergence of clone ST131 O25:H4
-
Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M b-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents. 2010;35:316-21. http://dx.doi.org/10.1016/j.ijantimicag.2009.11.003
-
(2010)
Int J Antimicrob Agents
, vol.35
, pp. 316-321
-
-
Peirano, G.1
Pitout, J.D.2
-
3
-
-
84906099443
-
A new clone sweeps clean: The enigmatic emergence of Escherichia coli sequence type 131.
-
Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother. 2014;58:4997-5004. http://dx.doi.org/10.1128/ AAC.02824-14
-
(2014)
Antimicrob Agents Chemother.
, vol.58
, pp. 4997-5004
-
-
Banerjee, R.1
Johnson, J.R.2
-
4
-
-
84870592622
-
Extraintestinal pathogenic Escherichia coli: An update on antimicrobial resistance, laboratory diagnosis and treatment.
-
Pitout JD. Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment. Expert Rev Anti Infect Ther. 2012;10:1165-76. http://dx.doi.org/10.1586/ eri.12.110
-
(2012)
Expert Rev Anti Infect Ther.
, vol.10
, pp. 1165-1176
-
-
-
5
-
-
84907000233
-
The difficult-to-control spread of carbapenemase producers in Enterobacteriaceae worldwide
-
Nordmann P, Poirel L. The difficult-to-control spread of carbapenemase producers in Enterobacteriaceae worldwide. Clin Microbiol Infect. 2014; 06. http://dx.doi.org/10.1111/1469-0691.12719
-
(2014)
Clin Microbiol Infect
, pp. 06
-
-
Nordmann, P.1
Poirel, L.2
-
6
-
-
84908104458
-
Performance Standards for Antimicrobial Susceptibility Testing: Twenty-third Informational Supplements.
-
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-third Informational Supplements. M100-S23. Wayne (PA): The InstitutA; 2013.p
-
(2013)
M100-S23. Wayne (PA): The InstitutA
-
-
-
7
-
-
84872025829
-
Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: First report of OXA-48-like enzymes in North America
-
Lascols C, Peirano G, Hackel M, Laupland KB, Pitout JD. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother. 2013;57:130-6. http://dx.doi.org/10.1128/AAC.01686-12
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 130-136
-
-
Lascols, C.1
Peirano, G.2
Hackel, M.3
Laupland, K.B.4
Pitout, J.D.5
-
8
-
-
80051695875
-
Ncreasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: Data from the SMART study (2009).
-
Lascols C, Hackel M, Marshall SH, Hujer AM, Bouchillon S, Badal R, et al. Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother. 2011;66:1992-7. http://dx.doi. org/10.1093/jac/dkr240
-
(2011)
J Antimicrob Chemother.
, vol.66
, pp. 1992-1997
-
-
Lascols, C.1
Hackel, M.2
Marshall, S.H.3
Hujer, A.M.4
Bouchillon, S.5
Badal, R.6
-
9
-
-
84887467705
-
Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E.
-
Banerjee R, Robicsek A, Kuskowski MA, Porter S, Johnston BD, Sokurenko E, et al. Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010. Antimicrob Agents Chemother. 2013;57:6385-8. http://dx.doi.org/10.1128/ AAC.01604-13
-
(2013)
Coli clinical isolates from the Chicago Region, 2007 to 2010. Antimicrob Agents Chemother.
, vol.57
, pp. 6385-6388
-
-
Banerjee, R.1
Robicsek, A.2
Kuskowski, M.A.3
Porter, S.4
Johnston, B.D.5
Sokurenko, E.6
-
10
-
-
84898633301
-
Rapid and specific detection, molecular pidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131
-
Johnson JR, Clermont O, Johnston B, Clabots C, Tchesnokova V, Sokurenko E, et al. Rapid and specific detection, molecular pidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J Clin Microbiol. 2014;52:1358-65. http://dx.doi.org/10.1128/JCM.03502-13
-
(2014)
J Clin Microbiol
, vol.52
, pp. 1358-1365
-
-
Johnson, J.R.1
Clermont, O.2
Johnston, B.3
Clabots, C.4
Tchesnokova, V.5
Sokurenko, E.6
-
11
-
-
84874263817
-
Abrupt emergence of a single dominant multidrugresistant strain of Escherichia coli
-
Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, et al. Abrupt emergence of a single dominant multidrugresistant strain of Escherichia coli. J Infect Dis. 2013;207:919-28. http://dx.doi.org/10.1093/infdis/jis933
-
(2013)
J Infect Dis
, vol.207
, pp. 919-928
-
-
Johnson, J.R.1
Tchesnokova, V.2
Johnston, B.3
Clabots, C.4
Roberts, P.L.5
Billig, M.6
-
12
-
-
84884798053
-
Four main virotypes among extended-spectrum-β- lactamase-producing isolates of Escherichia coli O25b:H4-B2- ST131: Bacterial, epidemiological, and clinical characteristics.
-
Blanco J, Mora A, Mamani R, Lopez C, Blanco M, Dahbi G, et al. Four main virotypes among extended-spectrum-β- lactamase-producing isolates of Escherichia coli O25b:H4-B2- ST131: bacterial, epidemiological, and clinical characteristics. J Clin Microbiol. 2013;51:3358-67. http://dx.doi.org/10.1128/ JCM.01555-13
-
(2013)
J Clin Microbiol.
, vol.51
, pp. 3358-3367
-
-
Blanco, J.1
Mora, A.2
Mamani, R.3
Lopez, C.4
Blanco, M.5
Dahbi, G.6
-
13
-
-
84893440771
-
Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China
-
Cai JC, Zhang R, Hu YY, Zhou HW, Chen GX. Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China. Antimicrob Agents Chemother. 2014;58:1146-52. http://dx.doi.org/10.1128/AAC.00912-13
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 1146-1152
-
-
Cai, J.C.1
Zhang, R.2
Hu, Y.Y.3
Zhou, H.W.4
Chen, G.X.5
-
14
-
-
84903192771
-
Molecular epidemiology of KPC-producing Escherichia coli: Occurrence of ST131-fimH30 subclone harboring pKpQIL-like IncFIIk plasmid
-
O’Hara JA, Hu F, Ahn C, Nelson J, Rivera JI, Pasculle AW, et al. Molecular epidemiology of KPC-producing Escherichia coli: occurrence of ST131-fimH30 subclone harboring pKpQIL-like IncFIIk plasmid. Antimicrob Agents Chemother. 2014;58:4234-7. http://dx.doi.org/10.1128/AAC.02182-13
-
(2014)
Antimicrob Agents Chemother
, vol.58
, pp. 4234-4237
-
-
O’hara, J.A.1
Hu, F.2
Ahn, C.3
Nelson, J.4
Rivera, J.I.5
Pasculle, A.W.6
-
15
-
-
84891591168
-
The epidemic of extended-spectrum-beta-lactamase- producing Escherichia coli ST131 is driven by a single highly pathogenic subclone
-
Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, et al. The epidemic of extended-spectrum-beta-lactamase- producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio 2013;4(6):e00377-13. http://dx.doi.org/10.1128/mBio.00377-13
-
(2013)
H30-Rx. MBio
, vol.4
, Issue.6
, pp. e00377-e00413
-
-
Price, L.B.1
Johnson, J.R.2
Aziz, M.3
Clabots, C.4
Johnston, B.5
Tchesnokova, V.6
|